Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Finance Watch: IPOs Are In A Slump, But Already Public Companies Have Rallied

Dec 13 2019

• By Mandy Jackson

Finance Watch

Related Content

Keeping Track, Oncology Edition: Biologic Breakthroughs And BLAs

Dec 11 2019

Mylan Gets Until April 2020 To Decide On Biosimilar Botox Collaboration With Revance

Sep 04 2019

Alnylam Wins FDA Approval For Givlaari, Its Second RNAi Drug

Nov 20 2019

Finance Watch: Genocea, Mateon Shift Strategies, Cut Jobs To Preserve Cash

Sep 28 2017

Biogen Growth Continues, But Analysts Worry About Near-Term R&D Prospects

Jul 23 2019

Pipeline Watch: Lumasiran, Empagliflozin Major Clinical Trial Starts

Nov 18 2019

Novartis To Pay $9.7bn For The Medicines Company

Nov 25 2019

Another Botox Competitor: Revance Prepares Longer-Lasting RT002 For BLA Submission

Feb 22 2019

Pipeline Watch: Phase III Readouts For Bimekizumab, RHB-104

Oct 21 2019

IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year

Jan 04 2019

IPO Update: 35 Biopharmas Provide -6.1% Average Return; New Offerings Feel Stock Market Impact

Oct 03 2019

Executives On The Move: Development Hires At BiomX And CytomX, Revance Chooses a CEO

Oct 24 2019

Aurinia Closing In On Lupus Nephritis With Voclosporin

Dec 05 2019

Seven Talking Points At ASH 2019

Dec 12 2019

Ardelyx Plans Mid-2020 NDA Filing For Tenapanor In Hyperphosphatemia

Dec 03 2019

Related Companies

89bio, Inc.

The Medicines Company

Alnylam Pharmaceuticals Inc.

Novartis AG

Ionis Pharmaceuticals, Inc.

Biogen, Inc.

Arrowhead Pharmaceuticals, Inc.

Johnson & Johnson

Kodiak Sciences Inc.

Immunomedics, Inc.

Constellation Pharmaceuticals, Inc.

Aurinia Pharmaceuticals Inc.

Forty Seven Inc.

Assembly Biosciences, Inc.

Ardelyx Inc.

Relmada Therapeutics, Inc.

Revance Therapeutics, Inc.

Allergan plc

Viatris Inc.

Rocket Pharmaceuticals Inc.

Inotek Pharmaceuticals Corporation

Additional Topics

Financing Business Strategies Innovation Deals Commercial BioPharmaceutical

More from Financing

More from Business

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.